
Nawal Merjaneh
Member, National Cancer Institute · University of Arizona College of Medicine - Phoenix
Credentials: · ·
History
Research
Journal of Perinatology · 2020 · First of 8 authors · Corresponding · 28 citations
The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer Treatment
Review · Cancers · 2024 · First of 5 authors · Corresponding · 25 citations
FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4
EMBO Molecular Medicine · 2024 · 17 citations

2 papers

1 paper
- AR
1 paper

1 paper · 1 as a resident

1 paper

1 paper

1 paper

1 paper
Clinical trials
- 2024–2028
Single Arm Romiplostim to Prevent CIT
Site PI · Recruiting · Early phase 1
Children's Hospital Medical Center, Cincinnati
- 2022–2030
Site PI · Recruiting · Phase 3
Children's Oncology Group




